相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metformin Prevents the Development of Oral Squamous Cell Carcinomas from Carcinogen-Induced Premalignant Lesions
Lynn Vitale-Cross et al.
CANCER PREVENTION RESEARCH (2012)
eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
Tommy Alain et al.
CANCER RESEARCH (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Translational Homeostasis via the mRNA Cap-Binding Protein, elF4E
Akiko Yanagiya et al.
MOLECULAR CELL (2012)
Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial growth factor
Vincent Vuiblet et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy
S. M. Hosseini-Moghaddam et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Pushing the Envelope in the mTOR Pathway: The Second Generation of Inhibitors
Eduardo Vilar et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
mToR signaling and drug development in cancer
Janet Dancey
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Kaposi's sarcoma and its associated herpesvirus
Enrique A. Mesri et al.
NATURE REVIEWS CANCER (2010)
Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma
P. Gasperini et al.
LEUKEMIA (2009)
Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis
Paola Gasperini et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression
Giovanni Stallone et al.
TRANSPLANT INTERNATIONAL (2008)
An NF-κB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia
D. Martin et al.
ONCOGENE (2008)
mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer
Stephen G. Dann et al.
TRENDS IN MOLECULAR MEDICINE (2007)
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: A cell and animal model of virally induced Kaposi's sarcoma
Agata D'Agostino Mutlu et al.
CANCER CELL (2007)
The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
Akrit Sodhi et al.
CANCER CELL (2006)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
G Stallone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor
A Sodhi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma
MB Atkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes
S Montaner et al.
CANCER CELL (2003)
Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site
L Bieleski et al.
JOURNAL OF VIROLOGY (2001)
分享论文
